Activating YAP in Mouse Retinal Glia Sparks Limited Neuron Regeneration

Retinal degenerative diseases—including age-related macular degeneration, glaucoma, and diabetic retinopathy—destroy neurons that the adult mammalian eye cannot replace. Zebrafish solve this problem elegantly: their Müller glia (MG) reprogram into retinal progenitor cells and regenerate functional neurons after injury. Understanding why mammalian MG fail to do the same, and whether the barrier can be overcome, is a central question in regenerative medicine.

This study focuses on YAP, the downstream effector of the Hippo signaling pathway. Earlier work from the same lab showed that injury transiently activates YAP in mouse MG, driving limited cell-cycle entry before Hippo signaling re-engages and forces withdrawal. Transgenic, constitutive expression of a Hippo-resistant YAP variant (YAP5SA) keeps MG proliferating indefinitely—but that persistent proliferative state prevents assessment of what daughter cells actually become. To solve this problem, the team packaged YAP5SA into an ShH10 AAV vector under a Gfap promoter, ensuring MG-specific expression. Because AAV genomes remain largely episomal, they dilute with each cell division, providing a built-in timer: YAP5SA expression fades as MG divide, allowing progeny to exit the cycle and differentiate.

A sophisticated intersectional lineage-tracing system layered Cre (from Glast-CreERT2) and FlpO (from the AAV) recombination over the R26R-Ai65 reporter, so tdTomato was activated only in AAV-infected MG and all their descendants. EdU pulse-labeling independently marked nuclei that had undergone DNA synthesis. Time-course immunofluorescence and flow cytometry confirmed robust MG proliferation at 14 days post-injection that completely ceased by 56 days, with no significant increase in apoptosis, validating the transient-activation model.

The critical lineage-tracing results were striking. At 56 and 112 days post-infection, tdTomato+/EdU+ cells were overwhelmingly SOX9+ MG. Flow cytometry analysis showed that only a small subset of progeny acquired markers consistent with bipolar-cell identity. No evidence emerged for photoreceptor or retinal ganglion cell regeneration. Single-cell transcriptomic profiling of YAP5SA-activated MG revealed a transcriptional state resembling late-stage embryonic retinal progenitors—cells already biased toward glial and bipolar fates—rather than the broad, multipotent early progenitors that can generate all retinal cell types.

The findings carry important implications for retinal regeneration strategies. YAP-mediated cell-cycle reentry is not a master switch that restores embryonic plasticity to adult MG. Instead, it primarily drives self-renewal, with limited and lineage-restricted neurogenic output. The bipolar-cell bias mirrors the late progenitor state and may reflect epigenetic constraints that persist through proliferation. The authors argue that overcoming these constraints—through additional transcription factor reprogramming, chromatin remodeling, or combinatorial signaling—will be necessary to achieve clinically meaningful neuron regeneration. The study also provides a methodological framework (intersectional tracing plus transcriptomics) that can benchmark future in vivo reprogramming approaches.